Last updated 2026-07-27
TL;DR
A certificate of analysis (COA) for a compounded arousal cream should confirm the active ingredient's identity and potency, usually sildenafil, plus purity and microbial testing. It cannot prove the cream works. No FDA-approved standard exists for scream cream, so a COA is your main window into what's actually in the jar and whether it matches the label.
What is a certificate of analysis for a compounded cream, exactly?
A certificate of analysis (COA) is a lab report tied to a specific batch of a compounded product. For a topical like scream cream, it typically documents the identity and concentration of the active ingredient (commonly sildenafil citrate), sometimes L-arginine content, and results for purity, potency, and contamination testing (microbial limits, occasionally heavy metals). It is not a government approval. It is not proof of safety or effectiveness. Think of it as a quality snapshot of one batch, made by or for the compounding pharmacy, usually through a third-party lab. The legal backbone here matters. Compounded drugs are regulated differently than commercially manufactured ones. Section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a) allows pharmacies to compound patient-specific prescriptions without going through the FDA's new drug approval process, provided they meet state board of pharmacy standards and don't compound copies of commercially available FDA-approved drugs [1]. That framework is exactly why a COA exists in the first place: nobody at the FDA is checking each batch, so the pharmacy (or you, the buyer) has to ask for the lab work instead. USP General Chapter 795 sets the compounding quality standards that non-sterile topicals like this cream generally fall under, covering things like beyond-use dating, ingredient verification, and documentation practices pharmacies are expected to follow [2].
Does scream cream have an FDA-approved standard formula?
No. There is no FDA-approved product called "scream cream," and no single standard recipe that every compounding pharmacy follows. This is one of the most misunderstood parts of the category. What pharmacies compound under this name usually centers on sildenafil citrate (the active ingredient in Viagra) mixed into a topical base, often with L-arginine added, and sometimes other agents like isosorbide dinitrate or additional vasodilators depending on the pharmacy's own formula. Concentrations vary. Bases vary. Preservative systems vary. That variability is exactly why a COA matters more here than it would for a standardized, mass-manufactured drug. When you buy a bottle of an FDA-approved medication, the manufacturing process itself is inspected and validated at scale. When you buy a compounded topical, each batch is its own small production run, and the COA is the only document that tells you what that specific run actually contained. If you're comparing potency or strength across pharmacies, start with Scream Cream Rx dosage to understand how strength claims on a label relate to what a COA should confirm.
What should a legitimate scream cream COA actually include?
| Batch or lot number | Ties the report to the actual jar you received | Generic COA reused across batches | |
|---|---|---|---|
| Active ingredient identity test | Confirms sildenafil (or stated actives) is actually present | No identity test, only a potency number | |
| Potency / assay result (% of label claim) | Whether the dose matches what's on the label, usually expected in a tight range like 90 to 110% | Potency wildly off-label or unreported | |
| Microbial testing | Screens for bacteria, yeast, mold in a topical applied to sensitive tissue | No microbial data on a water-containing cream | |
| Testing lab name | Shows a third party, more than an internal claim | Lab unnamed or unverifiable | |
| Test date and beyond-use date | Confirms the cream hasn't degraded past USP-recommended limits | No expiration or beyond-use date at all | USP 795 sets beyond-use date defaults for non-sterile compounds, generally capping water-containing topical formulations at a matter of weeks under refrigeration unless stability data supports longer, which is one reason an undated COA or an undated jar is a real problem [2]. If your pharmacy can't produce lot-specific paperwork on request, that's worth pausing on before you buy again. |
A useful COA is specific, dated, and batch-linked. At minimum, look for these elements. | Element | What it tells you | Red flag if missing |
What does a COA NOT tell you?
A COA tells you what's in the jar. It does not tell you whether the cream works for arousal, how your body will respond, or how it compares to an FDA-approved option. This distinction gets blurred constantly in marketing, so it's worth being blunt about it. A clean COA proves the sildenafil is real and roughly at the labeled strength. It says nothing about clinical efficacy, because efficacy requires controlled trials in actual patients, not a lab assay on a sample. The clinical evidence for topical sildenafil-based arousal creams is thin and mixed. Small studies have looked at topical or genital sildenafil application in women with arousal difficulty, with some reporting modest improvements in subjective arousal measures and others finding no meaningful difference from placebo. A randomized, placebo-controlled trial of topical alprostadil cream (a different vasodilator, applied topically) in postmenopausal women with female sexual arousal disorder, published in the Journal of Sexual Medicine, reported improvement over placebo on some measures but also highlighted how limited and mixed this research area remains [3]. Nobody has produced large, replicated, FDA-review-quality trials on the compounded topical creams sold today, and the formulas being sold now are often not identical to what was studied in any given trial anyway. That's a real gap, not a technicality.
How does scream cream compare to Addyi and Vyleesi?
| Scream cream (compounded) | Not FDA-approved, no standard formula | Local genital arousal/blood flow (claimed) | Topical cream | Formula and strength vary by pharmacy; efficacy evidence limited | |
|---|---|---|---|---|---|
| Addyi (flibanserin) | FDA-approved | Low sexual desire (HSDD), premenopausal women | Daily oral pill | Boxed warning for low blood pressure/fainting, alcohol interaction [4] | |
| Vyleesi (bremelanotide) | FDA-approved | Low sexual desire (HSDD), premenopausal women | As-needed injection | High rate of nausea in trials; blood pressure caution [5] | The honest summary: Addyi and Vyleesi went through full FDA clinical review for a specific diagnosis (HSDD) and carry documented, quantified side effect rates because of it. Scream cream has not gone through that process and treats a different complaint (arousal, not desire), so it isn't a substitute for either drug and isn't held to the same evidence bar. |
Addyi (flibanserin) and Vyleesi (bremelanotide) are the two FDA-approved prescription treatments for female sexual dysfunction, and both treat low sexual desire (hypoactive sexual desire disorder, HSDD), not local genital arousal. That's a different target than what scream cream claims to address. Addyi is a daily pill that works on brain neurotransmitter activity and carries a boxed warning about severe hypotension and syncope, especially when combined with alcohol; the FDA-approved label requires prescribers and pharmacies to be certified under a Risk Evaluation and Mitigation Strategy (REMS) and to counsel patients on avoiding alcohol [4]. Vyleesi is an as-needed injection taken before anticipated sexual activity, with common side effects including nausea (reported in the majority of trial participants), flushing, and injection site reactions, and it carries its own cautions around blood pressure [5]. | Product | FDA status | What it targets | Form | Key caution |
Who is legally allowed to make scream cream, and does that affect the COA?
Only licensed compounding pharmacies operating under state board of pharmacy oversight and federal 503A rules can legally compound a prescription product like this. That licensing status is part of why the COA question matters so much. A 503A pharmacy compounds for an individual patient with a valid prescription and is inspected by its state board of pharmacy, not the FDA directly, though FDA has authority to act against contamination or adulteration issues under 21 U.S.C. 353a [1]. A 503B outsourcing facility is a different category entirely, registered with FDA and permitted to compound in larger batches without a patient-specific prescription in advance, generally held to a higher, FDA-inspected quality standard (current Good Manufacturing Practice) under Section 503B of the FD&C Act (21 U.S.C. 353b) [6]. Ask which category your fulfilling pharmacy falls under. It changes what oversight exists behind the COA you're handed. Reputable telehealth or prescription routes for compounded products typically work with a named, licensed pharmacy partner precisely so that question has a clear answer rather than a vague one.
How do I read the potency number on a COA?
Look for a percentage tied to label claim, more than a raw milligram number floating alone. A result reading something like "sildenafil citrate, 98.4% of label claim" is meaningfully different from a bare "contains sildenafil." Compounding quality standards generally expect assayed potency to land within a defined range of the labeled strength, commonly discussed as roughly 90 to 110% in USP compounding guidance contexts, though the exact acceptable range can depend on the specific monograph and pharmacy protocol [2]. If a COA shows potency far outside that kind of range, or shows no percentage comparison to label claim at all, treat that as a real flag, not a formality. If you're trying to figure out what strength you were even prescribed in the first place, the Scream Cream Rx dosage calculator walks through how labeled strength, dose volume, and frequency relate, which is useful context before you evaluate whether a COA's potency number lines up with what you expected to receive.
What about contamination and microbial testing?
Topical creams that contain water are a viable environment for bacterial, yeast, and mold growth if compounding technique or preservation is off. Because this cream is applied to genital tissue, contamination risk is not a minor concern. USP 795 for non-sterile compounding sets expectations around ingredient sourcing, environmental controls, and, for many aqueous topical preparations, microbial limit testing or a documented rationale for skipping it [2]. A COA that reports total aerobic microbial count and absence of specific pathogens (like E. coli or Staphylococcus aureus) is doing its job. A COA silent on microbial testing for a cream you're applying to mucous membranes deserves a direct question to the pharmacy before use, not an assumption that it's fine.
Can I request a COA if my pharmacy didn't provide one?
Yes, and you should. Reputable compounding pharmacies expect this question and can usually produce lot-specific documentation on request, sometimes through the prescribing platform, sometimes directly from the pharmacy. If a pharmacy refuses, stalls indefinitely, or gives you a generic marketing sheet instead of an actual lab report tied to your batch, that's a legitimate reason to look elsewhere. You are not being difficult by asking. Given how much formulas and strengths vary pharmacy to pharmacy, a COA is often the only concrete evidence you'll get about what's actually in your specific jar. At Scream Cream Rx, the provider-reviewed route is built around naming the fulfilling pharmacy partner directly rather than leaving that detail vague, precisely so this kind of documentation request has an obvious place to go.
What questions should I ask my pharmacy before buying?
Bring a short, specific list rather than a vague "is this safe" question. Useful ones: Is there a current COA for the exact batch/lot I'll receive, not a generic template? What is the assayed potency as a percentage of label claim? Was microbial testing performed, and what were the results? What is the beyond-use date, and how was it determined? Is this pharmacy a 503A compounding pharmacy or a 503B outsourcing facility, and is it in good standing with its state board? If you're also working out logistics like how to store, mix, or apply the cream once you have it, how to reconstitute Scream Cream Rx and Scream Cream Rx cycle length cover the practical side once the sourcing question is settled.
Is a COA required by law for compounded creams?
Not in the sense of a single federal mandate specifically requiring a public-facing COA for every compounded prescription. What is required is that compounding pharmacies follow USP compounding chapters and state board of pharmacy rules, which include ingredient verification and quality assurance expectations, and that they don't misrepresent 503A compounding as a copy of an FDA-approved commercial product [1] [2]. In practice, whether you personally receive a COA is often a matter of pharmacy policy and how you ask, not a guaranteed legal entitlement spelled out on a form. That's an uncomfortable gap for consumers, and it's exactly why picking a pharmacy partner that volunteers this documentation, rather than one you have to fight for it from, is worth prioritizing.
Frequently asked questions
What is a certificate of analysis for scream cream?
It's a batch-specific lab report showing the identity and potency of the active ingredient (usually sildenafil citrate), often plus purity and microbial test results. It confirms what's physically in a given jar. It does not confirm the product works for arousal, since that requires clinical trial evidence, not a lab assay.
Is scream cream FDA-approved?
No. Scream cream is a compounded product, not an FDA-approved drug, and there's no single standard formula across pharmacies. It's typically made under FDA's 503A compounding framework, which allows patient-specific compounding without full FDA new drug review, unlike Addyi or Vyleesi [1].
What ingredients are usually in scream cream?
Most commonly sildenafil citrate in a topical base, often combined with L-arginine, and sometimes other vasodilating agents depending on the compounding pharmacy's own formula. Concentrations and added ingredients vary by pharmacy, so you cannot assume one recipe applies across brands or providers.
How is scream cream different from Addyi or Vyleesi?
Addyi and Vyleesi are FDA-approved and treat low sexual desire (HSDD) through oral or injectable dosing, with documented side effect rates from clinical trials [4][5]. Scream cream is a compounded topical aimed at local arousal, not desire, and hasn't gone through FDA clinical review, so its evidence base is much thinner.
Does topical sildenafil cream actually work for female arousal?
Evidence is limited and mixed. Some small studies show modest subjective improvement, while a placebo-controlled trial of a related topical vasodilator cream in postmenopausal women showed only partial benefit on select measures [3]. No large, FDA-quality trials exist for the specific compounded formulas sold today.
What potency range should a COA show?
Look for an assayed potency reported as a percentage of label claim, commonly discussed in compounding standards around a 90 to 110% range depending on the monograph, rather than a bare milligram number with no comparison to what the label states [2].
Should a scream cream COA include microbial testing?
Ideally yes, since it's a water-containing topical applied to sensitive tissue. USP 795 non-sterile compounding standards address microbial limit expectations and environmental controls for this kind of aqueous preparation [2]. A COA silent on microbial results is worth questioning directly.
Can I ask my compounding pharmacy for a COA?
Yes. Reputable pharmacies can generally provide lot-specific documentation on request. If a pharmacy stalls or gives you generic marketing material instead of an actual lab report, treat that as a reason to ask more questions or look elsewhere.
What's the difference between a 503A and 503B pharmacy?
A 503A pharmacy compounds patient-specific prescriptions under state board oversight; a 503B outsourcing facility registers with FDA and can produce larger batches without a prior patient-specific prescription, generally under stricter FDA-inspected manufacturing standards [1][6]. Ask which category applies to whoever fulfills your prescription.
How long is scream cream good for after compounding?
Beyond-use dating for non-sterile, water-containing topical compounds is generally short, often weeks under refrigeration, under USP 795 defaults unless the pharmacy has specific stability data supporting a longer date [2]. Your COA or label should state a beyond-use date; if it doesn't, ask.
Does a clean COA mean scream cream is safe to use?
Not entirely. A clean COA means the batch matches its label for identity, potency, and contamination testing. It doesn't rule out individual reactions, doesn't confirm effectiveness, and doesn't replace a conversation with a prescriber about your health history and any medications you take.
Why do scream cream formulas differ between pharmacies?
Because there's no FDA-approved standard formula, each compounding pharmacy sets its own recipe, active ingredient concentration, and base under 503A rules and USP 795 quality standards [1][2]. That's exactly why checking a COA and asking direct questions matters more here than with a standardized commercial drug.
Sources
- 21 U.S.C. 353a, Pharmacy compounding (FD&C Act Section 503A): 503A compounding pharmacies can compound patient-specific prescriptions without FDA new drug approval, under state board oversight, and cannot copy commercially available FDA-approved drugs
- USP, General Chapter <795> Pharmaceutical Compounding - Nonsterile Preparations: USP 795 sets quality, testing, and beyond-use dating standards for non-sterile compounded preparations like topical creams
- Journal of Sexual Medicine, randomized trial of topical alprostadil cream for female sexual arousal disorder (PMID: 18042220): A placebo-controlled trial of a topical vasodilator cream in postmenopausal women with FSAD showed only partial benefit on select arousal measures, illustrating the mixed evidence base
- FDA-approved drug label, Addyi (flibanserin) tablets, Application Number 022526: Addyi carries a boxed warning for severe hypotension and syncope, particularly with alcohol, and requires certified prescriber and pharmacy participation under a REMS program
- FDA-approved drug label, Vyleesi (bremelanotide) injection, Application Number 210557: Vyleesi is an as-needed injectable for HSDD with nausea reported in the majority of clinical trial participants and blood pressure cautions
- 21 U.S.C. 353b, Outsourcing facilities (FD&C Act Section 503B): 503B outsourcing facilities register with FDA and can compound in larger batches without a prior patient-specific prescription under stricter manufacturing oversight